Video – UPDATED: How to best make use of the FDA and PDUFA Calendars
Apr 15, 2012
No Comments
Archive for Video
Latest Articles
Chatroom has been upgraded – Live now!!
Dear BioPharmCatalyst reader, I am pleased to announce that the chatroom has had a complete revamp for the benefit of all users of BioPharmCatalyst. The previous chatroom was admittedly poorly designed and as a result received little attention. It was not user-friendly and in fact most readers were unaware it existed. However, as of today [...]
NBIX releases Phase 2 data. NBY and SPPI initiate Phase 2 trials
Spectrum Pharmaceuticals (NasdaqGS: SPPI) announced the initiation of a Phase 2 trial of ZEVALIN for intravenous use + rituximab in combination with motexafin gadolinium (MGd) in patients with rituximab-refractory low-grade or follicular B-cell non-Hodgkin’s lymphoma (NHL). Neurocrine Biosciences, Inc. (NASDAQ: NBIX) announced efficacy and safety results from its Phase 2 trial of urocortin 2 in 53 patients [...]
Abstracts have been added to the ASCO Calendar!
Earlier today abstracts to next month’s ASCO meeting were released. Approximately 75 of those abstracts can now be found in the BioPharmCatalyst ASCO Calendar, which can be found HERE. Session times and other information can also be found to give you a one-stop resource provided to save you much time in searching for abstracts.
Sign up me up now!
For content updates enter your email address below.
Recent Comments